The company also reported that revenues for the first nine months of 2009 increased 4 percent over the same period last year, to a record $83.1 million.
Cryolife is an implantable biological medical device and cardiovascular tissue processing company.
Read Crylife’s release on third-quarter revenues.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
